Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)
Recruiting
Who can join
1 Day – 12 Months · All sexes
Full eligibility criteria
Inclusion Criteria: * \- Neonates and infants (\< 12 months) * Hemodynamically stable * Undergoing a lumbar puncture for diagnostic testing Exclusion Criteria: * \- Infants \> 12 months and 1 day * Signs of clinical instability * Known spinal anomalies (e.g., spina bifida, meningomyelocele) or previous spinal surgery
About the study
This is a clinical trial to determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF that is interpretable for patient management.
What is being tested
- ultrasound contrast (device)
Sponsor: Vanderbilt University Medical Center · Participants: 80 · Started: May 16, 2026
Contact the study team
- Donald H Arnold, MD, MPH · Phone: 615-936-4498
Official record on ClinicalTrials.gov — NCT07612644
Locations in the U.S.
| Tennessee | Vanderbilt University Medical Center, Nashville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.